/RADLY
RADLY Stock - Raia Drogasil S.A.
Healthcare|Medical - PharmaceuticalsOTC
$4.13+0.00%
+$0.00 (+0.00%) • Dec 19
75
GoAI Score
GoAI Score
Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.BUY
Medium Confidence
Momentum
Momentum Score
Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.81
Sentiment
Sentiment Score
Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).70
Risk Score
Risk Score
Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.100
Price Target
Price Target
Average analyst price target from the last quarter. Shows expected upside/downside from current price.+10.0%upside
Target: $4.54
AI Analysis PreviewPremium
Real-time AI-powered market analysis
Precise entry/exit price targets
Risk assessment & position sizing
Unlock GoAI Insights for RADLY
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Buy/Sell Signals
94% win rate on Alpha signals
Deep Analysis
Institutional-grade thesis
Real-Time Alerts
SMS & push notifications
Risk Scoring
Multi-factor analysis
Free 14-day trial • No credit card required
Active Trade Setup
ENTRY ZONE$4.08 – $4.17
TARGET (TP)$4.74
STOP LOSS$3.80
RISK/REWARD1:1.9
Premium members get real-time SMS alerts
Price Chart
Financial Statements
Revenue & Profitability Trend
← Swipe to see more →
Revenue
Net Income (Profit)
Net Loss
Key Metrics
Market CapN/A
P/E RatioN/A
Beta0.09
52W High$4.95
52W Low$2.21
Avg VolumeN/A
Income Statement (Fiscal Year)
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | $38.86B | $33.97B | $29.07B | $24.13B | $20.07B |
| Gross Profit | $11.55B | $10.21B | $8.81B | $7.21B | $5.89B |
| Gross Margin | 29.7% | 30.0% | 30.3% | 29.9% | 29.4% |
| Operating Income | $2.37B | $2.08B | $1.48B | $1.22B | $854.20M |
| Net Income | $1.20B | $1.05B | $996.11M | $751.93M | $484.44M |
| Net Margin | 3.1% | 3.1% | 3.4% | 3.1% | 2.4% |
| EPS | $0.73 | $0.62 | $0.58 | $0.44 | $0.28 |
Company Overview
Raia Drogasil S.A. engages in the retail sale of medicines, perfumery, personal care and beauty products, cosmetics, dermocosmetics, and specialty medicines in Brazil. As of March 31, 2022, the company operated a network of 2,530 drug stores in 26 Brazilian states. It also markets its goods through telesales and its three call centers in the states of São Paulo, Tocantins, and Pernambuco. The company was founded in 1905 and is headquartered in São Paulo, Brazil.
Visit WebsiteLoading analyst ratings...
Earnings History & Surprises
RADLYBeat Rate
43%
Last 14 quarters
Avg Surprise
+3.5%
EPS vs Estimate
Beats / Misses
6/8
Last 12 quarters
Latest EPS
$0.05
Q4 2025
EPS Surprise History
Q4 23
No data
Q2 24
-23.0%
$0.02vs$0.03
Q3 24
-15.0%
$0.04vs$0.04
Q4 24
+20.3%
$0.04vs$0.03
Q1 25
+23.6%
$0.03vs$0.03
Q2 25
-29.9%
$0.02vs$0.02
Q3 25
+38.7%
$0.04vs$0.03
Q4 25
+30.1%
$0.05vs$0.04
Beat Estimate
Missed Estimate
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q2 2026 | May 4, 2026 | — | — | — | — |
Q1 2026 | Feb 23, 2026 | — | — | — | — |
Q4 2025 | Nov 5, 2025 | $0.04 | $0.05 | +30.1% | ✓ BEAT |
Q3 2025 | Aug 5, 2025 | $0.03 | $0.04 | +38.7% | ✓ BEAT |
Q2 2025 | May 5, 2025 | $0.02 | $0.02 | -29.9% | ✗ MISS |
Q1 2025 | Feb 25, 2025 | $0.03 | $0.03 | +23.6% | ✓ BEAT |
Q4 2024 | Nov 5, 2024 | $0.03 | $0.04 | +20.3% | ✓ BEAT |
Q3 2024 | Aug 6, 2024 | $0.04 | $0.04 | -15.0% | ✗ MISS |
Q2 2024 | May 7, 2024 | $0.03 | $0.02 | -23.0% | ✗ MISS |
Q4 2023 | Dec 31, 2023 | — | $0.03 | — | — |
Q3 2023 | Sep 30, 2023 | $0.03 | $0.03 | -8.5% | ✗ MISS |
Q2 2023 | Jun 30, 2023 | $0.04 | $0.04 | -0.5% | ✗ MISS |
Q1 2023 | Mar 31, 2023 | $0.02 | $0.02 | -6.0% | ✗ MISS |
Q4 2022 | Dec 31, 2022 | — | $0.03 | — | — |
Q3 2022 | Sep 30, 2022 | $0.02 | $0.02 | -2.5% | ✗ MISS |
Q2 2022 | Jun 30, 2022 | $0.03 | $0.04 | +41.1% | ✓ BEAT |
Q1 2022 | Mar 31, 2022 | $0.02 | $0.02 | +1.7% | ✓ BEAT |
Q4 2021 | Dec 31, 2021 | $0.02 | $0.02 | -21.2% | ✗ MISS |
Q3 2021 | Sep 30, 2021 | — | $0.02 | — | — |
Q2 2021 | Jun 30, 2021 | — | $0.03 | — | — |
Latest News
Loading news...
Frequently Asked Questions about RADLY
What is RADLY's current stock price?
Raia Drogasil S.A. (RADLY) is currently trading at $4.13 per share. The stock has moved +0.00% today.
What is the analyst price target for RADLY?
No analyst price targets are currently available for this stock.
What sector is Raia Drogasil S.A. in?
Raia Drogasil S.A. operates in the Healthcare sector, specifically within the Medical - Pharmaceuticals industry. The company is traded on the OTC exchange.
What is RADLY's market cap?
Raia Drogasil S.A. has a market capitalization of $6.80 billion, making it a mid-cap company.
Does RADLY pay dividends?
No, Raia Drogasil S.A. does not currently pay a dividend to shareholders.
Similar Stocks
Healthcare SectorCLCGY
Clicks Group Limited
$39.86
Mkt Cap: $4.7B
CNVVF
ConvaTec Group Plc
$3.06
Mkt Cap: $6.3B
CNVVY
ConvaTec Group Plc
$12.86
Mkt Cap: $6.6B
CSMYF
COSMOS Pharmaceutical Corporation
$48.27
Mkt Cap: $3.8B
DSRLF
DiaSorin S.p.A.
$74.34
Mkt Cap: $4.0B
FLMNF
Fielmann AG
$60.22
Mkt Cap: $5.1B
GNGBY
Getinge AB (publ)
$22.99
Mkt Cap: $6.3B
MSMKF
MatsukiyoCocokara & Co.
$18.17
Mkt Cap: $7.2B
SHPMY
Shanghai Pharmaceuticals Holding Co., Ltd
$8.23
Mkt Cap: $6.1B
WLCGF
Welcia Holdings Co., Ltd.
$16.41
Mkt Cap: $3.4B
Explore stocks similar to RADLY for comparison